New York, April 24: Ultrahuman, a prominent player in the smart ring market, today announced its strategic expansion plans with the establishment of a new manufacturing facility, the UltraFactory, in Indiana.
The company aims to commence operations within the next six months, marking a significant step in its quest to dominate the smart ring sector.
This initiative follows a successful $35 million Series B funding round, underscoring Ultrahuman’s commitment to seizing market leadership in the upcoming 12 to 15 months. The Indiana-based UltraFactory, modeled after the company’s first production facility in India, is designed to enhance end-to-end manufacturing capabilities, potentially increasing annual revenue by $100 million through the addition of 200,000 smart rings to its production capacity.
Ultrahuman’s Founder and CEO, Mohit Kumar, highlighted the strategic importance of the U.S. market, stating, “US is an interesting market for us given it has always been huge in terms of demand for the product but we’re also seeing tremendous value from a manufacturing and research perspective. UltraFactory US would enable manufacturing for health tracking smart ring devices and give us the ability to do necessary research to evolve the form factor further.”
The company’s expansion into the U.S. aligns with its broader strategy to optimize manufacturing efficiencies and capitalize on the increasing domestic demand for tech-driven health solutions. This move is also set to support the U.S. government’s initiative to bolster domestic production and reduce reliance on overseas manufacturing, primarily from China.
Over the next 12 months, Ultrahuman plans to hire 150 new employees in the U.S., dividing roles between engineering, research, and commercial operations. These new jobs will support the company’s dynamic growth, which has seen Ultrahuman become the second-largest player in the smart ring market while maintaining profitability.
“Our vision of being the top player in terms of both active devices and geographic presence is within reach, thanks to our rapid expansion and the love we’ve received from our users,” Kumar added.
The expansion not only supports Ultrahuman’s manufacturing capabilities but also complements its recent retail growth, with products now available in prestigious locations worldwide including London’s Selfridges, Changi Airport in Singapore, and the Virgin Megastore in Dubai.
Kumar emphasized the company’s dedication to continuous improvement and user satisfaction: “Shipping a new firmware version every two weeks and weekly app improvements reflect our commitment to excellence and our speed of execution, our biggest competitive advantage. We’ve also iterated on hardware at the speed of software by designing novel devices like Ultrahuman Home, a home health monitor.”
With these developments, Ultrahuman is on a clear path to surpass $100 million in annualized revenue run rate (ARR) by the end of 2024, achieving this milestone profitably. This growth trajectory is supported by the company’s robust R&D efforts and a recent clinical trial involving 105 participants, aimed at validating the ‘Metabolic Score’ generated on the Ultrahuman platform.
Kumar concluded, “Our long-term investment in R&D and intellectual property is a cornerstone of our strategy, ensuring that our products not only meet but exceed the highest standards of efficacy and reliability.”
Media & PR: editor@dailystraits.com. Copyright 2021–Present DailyStraits.com. All rights reserved.